journal article·2026-01Open access

Imaging of Lipid Droplets in Living Cells and Mice with Metabolic Dysfunction‐Associated Steatotic Liver Disease via a Galactose‐Modified Supramolecular Near‐Infrared Fluorescent Glycoprobe

Han‐Min Wang, Lei Dong, Qiu‐Lian Hao, Lu‐Lu Sun, Xin‐Rong Li, Yu‐Wei Yuan, Ming‐Ye Tang, Jin Gong, Yi Zang, Jia Li, Tony D. James, Xiao‐Peng He, Hai‐Hao Han

Advanced Functional Materials· Volume 36· Issue 3

Abstract

Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) has become an important liver disease worldwide due to the rising rate of type 2 diabetes, obesity, and other metabolic disorders. The early detection of MASLD is vital to slow progression to cirrhosis and hepatocellular carcinoma; yet, existing research tools for studying hepatic steatosis are limited in terms of their effectiveness and invasiveness. Herein, a near‐infrared (NIR) fluorescent probe, TCF‐FBN, for the selective imaging of lipid droplets (LDs) in MASLD is reported. TCF‐FBN exhibits bright NIR fluorescence and a large Stokes shift in nonpolar solvents, and minimal fluorescence in polar solvents, making it suitable for biological imaging. The probe is bound to bovine serum albumin (BSA) through supramolecular forces to enhance its biocompatibility, and the resulting TCF‐FBN@BSA ensemble is used for fluorescence imaging of LDs generated in hepatocytes. Notably, the modification of TCF‐FBN@BSA with galactosyl ligands producing TCF‐FBN@Gal‐BSA enables the targeted imaging of the liver of mice with MASLD via asialoglycoprotein receptor (ASGPR)‐mediated biorecognition.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipid metabolism and biosynthesis · Liver Disease Diagnosis and Treatment · Pancreatic function and diabetes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shandong Laboratory of Yantai Drug Discovery Bohai Rim Advanced Research Institute for Drug Discovery Yantai Shandong 264117 P. R. China

Molecular Imaging Center National Center for Drug Screening Stake Key Laboratory of Chemical Biology Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 P. R. China

School of Pharmacy Shandong Second Medical University Weifang 261053 P. R. China

University of Chinese Academy of Sciences No. 19A Yuquan Road Beijing 100049 P. R. China

Affiliated Huishan Hospital of Xinglin College Nantong University Wuxi Huishan District People's Hospital Wuxi Jiangsu 214187 P. R. China

Lingang laboratory Shanghai 201203 P. R. China

Department of Chemistry University of Bath Bath BA2 7AY UK

School of Chemistry and Chemical Engineering Henan Normal University Xinxiang 453007 P. R. China

Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering Feringa Nobel Prize Scientist Joint Research Center Frontiers Center for Materiobiology and Dynamic Chemistry School of Chemistry and Molecular Engineering East China University of Science and Technology 130 Meilong Rd. Shanghai 200237 P. R. China

The International Cooperation Laboratory on Signal Transduction National Center for Liver Cancer Eastern Hepatobiliary Surgery Hospital Shanghai 200438 P. R. China

Funding

National Natural Science Foundation of China · Science and Technology Commission of Shanghai Municipality · Fundamental Research Funds for the Central Universities · Natural Science Foundation of Shandong Province

References (44)

Show source-provided references
1. 10.1038/s41575-022-00635-510.1038/s41575-022-00635-5 ↗
2. 10.3390/cancers1606121410.3390/cancers16061214 ↗
3. 10.1016/j.jhepr.2021.10032210.1016/j.jhepr.2021.100322 ↗
4. 10.3390/jcm1005092410.3390/jcm10050924 ↗
5. 10.1016/j.jhep.2020.03.03910.1016/j.jhep.2020.03.039 ↗
6. 10.3390/diagnostics1202040710.3390/diagnostics12020407 ↗
7. 10.1007/s13679-024-00574-z10.1007/s13679-024-00574-z ↗
8. 10.1039/D0CS01183E10.1039/D0CS01183E ↗
9. 10.1021/jacs.1c0795410.1021/jacs.1c07954 ↗
10. 10.1039/D2CS00673A10.1039/D2CS00673A ↗
11. 10.1021/acs.analchem.3c0000710.1021/acs.analchem.3c00007 ↗
12. 10.1039/D3SC05010F10.1039/D3SC05010F ↗
13. 10.1016/j.cclet.2024.10960310.1016/j.cclet.2024.109603 ↗
14. 10.1016/j.cclet.2024.10983410.1016/j.cclet.2024.109834 ↗
15. 10.1016/j.talanta.2023.12552610.1016/j.talanta.2023.125526 ↗
16. 10.1038/s44222-022-00002-810.1038/s44222-022-00002-8 ↗
17. 10.1002/VIW.2020006810.1002/VIW.20200068 ↗
18. 10.1002/ird3.1010.1002/ird3.10 ↗
19. 10.1016/j.jhep.2021.11.00910.1016/j.jhep.2021.11.009 ↗
20. 10.1016/j.ccr.2020.21357710.1016/j.ccr.2020.213577 ↗
21. 10.1002/adfm.20230362710.1002/adfm.202303627 ↗
22. 10.1002/adfm.20210992910.1002/adfm.202109929 ↗
23. 10.1039/D1CC05717K10.1039/D1CC05717K ↗
24. 10.1039/D4TB01741B10.1039/D4TB01741B ↗
25. 10.1096/fasebj.6.13.139784110.1096/fasebj.6.13.1397841 ↗
26. 10.1021/ar00056a00110.1021/ar00056a001 ↗
27. 10.1039/D1CC06809A10.1039/D1CC06809A ↗
28. 10.1021/jacs.0c0537910.1021/jacs.0c05379 ↗
29. 10.1021/jacs.8b0542510.1021/jacs.8b05425 ↗
30. 10.1002/anie.20160612110.1002/anie.201606121 ↗
31. 10.1039/D1SC05057E10.1039/D1SC05057E ↗
32. 10.1021/acsami.7b0748510.1021/acsami.7b07485 ↗
33. 10.1021/jacs.4c0617210.1021/jacs.4c06172 ↗
34. 10.1073/pnas.240871612110.1073/pnas.2408716121 ↗
35. 10.1016/j.chempr.2022.03.01210.1016/j.chempr.2022.03.012 ↗
36. 10.1002/INMD.2024001010.1002/INMD.20240010 ↗
37. 10.1021/jacs.3c0505210.1021/jacs.3c05052 ↗
38. 10.1016/j.dyepig.2015.12.01310.1016/j.dyepig.2015.12.013 ↗
39. 10.1021/acs.analchem.3c0205310.1021/acs.analchem.3c02053 ↗
40. Kuchay M. S. · Clin. Res. Rev. · 2020 · 14 · 1875
41. 10.1194/jlr.M08193510.1194/jlr.M081935 ↗
42. 10.1016/j.chembiol.2022.12.00310.1016/j.chembiol.2022.12.003 ↗
43. 10.1038/s41589-021-00770-110.1038/s41589-021-00770-1 ↗
44. 10.1039/C7CC04525E10.1039/C7CC04525E ↗